|
|
|
|
LEADER |
01919nam a2200193Ia 4500 |
001 |
10.7314-APJCP.2014.15.10.4261 |
008 |
220127s2014 CNT 000 0 und d |
020 |
|
|
|a 1513-7368
|
245 |
1 |
0 |
|a Comparison of Psychotropic Prescriptions between Oncology and Cardiology Inpatients: Result from a Pharmacy Database in a Teaching Hospital in Malaysia
|
490 |
1 |
0 |
|t ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.7314/APJCP.2014.15.10.4261
|
520 |
3 |
|
|a Objective: To examine the prescription rates in cancer patients of three common psychotropic drugs: anxiolytic/hypnotic, antidepressant and antipsychotic. Materials and Methods: In this retrospective cohort study, data were extracted from the pharmacy database of University Malaya Medical Center (UMMC) responsible for dispensing records of patients stored in the pharmacy's Medication Management and Use System (Ascribe). We analyzed the use of psychotropics in patients from the oncology ward and cardiology from 2008 to 2012. Odds ratios (ORs) were adjusted for age, gender and ethnicity. Results: A total of 3,345 oncology patients and 8,980 cardiology patients were included. Oncology patients were significantly more often prescribed psychotropic drugs (adjusted OR: anxiolytic/hypnotic = 5.55 (CI: 4.64-6.63); antidepressants = 6.08 (CI: 4.83-7.64) and antipsychotics = 5.41 (CI: 4.17-7.02). Non-Malay female cancer patients were at significantly higher risk of anxiolytic/hypnotic use. Conclusions: Psychotropic drugs prescription is common in cancer patients. Anxiolytic/hypnotic prescription rates are significantly higher in non-Malay female patients in Malaysia.
|
700 |
1 |
0 |
|a Haris, A
|e author
|
700 |
1 |
0 |
|a Mohamed, S
|e author
|
700 |
1 |
0 |
|a Ng, CG
|e author
|
700 |
1 |
0 |
|a Sulaiman, AH
|e author
|
700 |
1 |
0 |
|a Wern, TY
|e author
|
700 |
1 |
0 |
|a Zainal, NZ
|e author
|
773 |
1 |
0 |
|t ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
|